RESUMO Contexto: O papel dos alimentos lácteos na doença inflamatória intestinal (DII) tem sido controverso e é discutível se os pacientes com DII devem ou não evitar leite e laticínios, bem como a relação entre esses alimentos e sintomas nesta população. Objetivo: Estudo transversal multicêntrico foi projetado para avaliar se é realmente necessário privar os pacientes com DII do consumo desta classe de alimentos. Métodos: Um estudo multicêntrico com 12 centros de referência em gastroenterologia de quatro países foi projetado para avaliar sintomas gastrointestinais após o consumo de alimentos lácteos em todos os ambulatórios de DII durante seis meses e comparar pacientes tratados nos mesmos centros sem DII. Resultados: No total, foram incluídos 1888 casos (872 pacientes com DII e 1016 casos sem DII. 56,6% dos participantes eram do sexo feminino com idade média de 40,1 anos. 79,8% dos participantes eram caucasianos e originalmente eram cidadãos de 10 países. A prevalência relativa de DII foi maior em africanos e indianos e a prevalência mais frequente de intolerância a alimentos lácteos observada nos asiáticos. Entre os pacientes com DII, 571 casos foram diagnosticados como colite ulcerativa e 189 participantes como doença de Crohn. A duração média do diagnóstico como DII foi de 6,8 anos (de 2 meses a 35 anos). Os sintomas de gastrointestinais mais prevalentes após o consumo de todos os alimentos lácteos foram inchaço e dor abdominal. No total, a intolerância aos alimentos lácteos e a deficiência de lactase foi mais prevalente entre os pacientes com DII em comparação com os casos sem DII (65,5% vs 46,1%, P=0,0001). A taxa de queixas gastrointestinais entre os pacientes com DII que não tinham histórico familiar de deficiência de lactase, histórico de sensibilidade alimentar ou ambos foram de 59,91%, 52,87% e 50,33% respectivamente e semelhantes aos casos sem DII (P=0,68, 0,98 e 0,99, respectivamente). Conclusão: A taxa de intolerância de alimentos lácteos entre pacientes com DII sem histórico familiar de deficiência de lactase ou histórico de sensibilidade alimentar é semelhante aos casos sem DII e provavelmente não há razão para privá-los dessa importante fonte de cálcio dietético, vitamina D e outros nutrientes.

ABSTRACT Background: The role of dairy foods in inflammatory bowel disease (IBD) has been controversial and it is debatable if patients with IBD should avoid milk and dairy products or not, as well as the relationship between these foods and symptoms among those population. Objective: This multi centric cross-sectional study designed to evaluate if it is really necessary to deprive IBD patients from consumption of dairy foods. Methods: A multicenter study with 12 gastroenterology referral centers in four countries was designed to evaluate gastrointestinal (GI) symptoms after consumption of dairy foods from all outpatients with IBD during 6 months and to compare patients treated at the same centers without IBD (non IBD cases). Results: Overall 1888 cases included (872 IBD patients and 1016 non IBD cases). 56.6% of participants were female with average age of 40.1 years. Racially 79.8% participants were Caucasians and originally they were citizens of 10 countries. Relative prevalence of IBD was higher in Africans and Indians and the most frequent prevalence of dairy foods intolerance was seen in Asians. Among IBD patients, 571 cases diagnosed as ulcerative colitis and 189 participants as Crohn’s disease. Average duration of diagnosis as IBD was 6.8 years (from 2 months to 35 years). The most prevalent GI symptoms after consumption of all the dairy foods were bloating and abdominal pain. Totally, intolerance of dairy foods and lactase deficiency was more prevalent among IBD patients in comparison with non IBD cases (65.5% vs 46.1%, P=0.0001). But the rate of GI complains among IBD patients who had not any family history of lactase deficiency, history of food sensitivity or both were 59.91%, 52.87% & 50.33% respectively and similar to non IBD cases (P=0.68, 0.98 & 0.99 respectively). Conclusion: The rate of dairy foods intolerance among IBD patients without family history of lactase deficiency or history of food sensitivity is similar to non IBD cases and probably there is no reason to deprive them from this important source of dietary calcium, vitamin D and other nutrients.

ABSTRACT In this study, the aerosol direct, semi-direct and indirect effects on the East Asia climate are investigated using the International Center for Theoretical Physics Regional Climate Model v. 4 (RegCM4.1.1), by focusing on the East Asian Summer Monsoon temperature and precipitation. The externally mixed aerosols, including sulfate (SO4 2-), black carbon and organic carbon, reduced the solar flux reaching the surface directly by scattering solar radiation, and indirectly by increasing the cloud droplet concentration and cloud liquid water path over East China. The combined aerosol effects (direct and indirect) decreased the temperature on the continent and increased it over the oceans, leading to the reduction of rainfall in the central regions of China and an enhancement of rainfall in the adjacent ocean regions.

RESUMEN En este estudio se investigan los efectos directos, semidirectos e indirectos de los aerosoles en el clima del este de Asia, utilizando para ello el Modelo Climático Regional v. 4 (RegCM4.1.1, por sus siglas en inglés) del Centro Internacional de Física Teórica, para lo cual la investigación se centra en la temperatura y precipitación del monzón de verano del este de Asia. Los aerosoles mezclados externamente, incluyendo sulfato (SO4 2-), carbono negro y carbono orgánico, redujeron el flujo solar que llega a la superficie, directamente mediante la dispersión de la radiación solar, y de manera indirecta incrementando la concentración de gotitas de agua en las nubes y el contenido de agua liquida integrada en la columna vertical sobre el este de China. Los efectos combinados (directos e indirectos) de los aerosoles redujeron la temperatura en el continente y la incrementaron en los océanos, lo que condujo a la reducción de precipitaciones en las regiones centrales de China y a su mejoramiento en las zonas adyacentes de los océanos.

Resumo Objetivo Nosso estudo visou determinar quais espécies de fitoplâncton, como alimento natural, podem ser ingeridas e digeridas pela tilápia do Nilo (Oreochromis niloticus L.). Métodos Durante o estudo, coletamos e analisamos o fitoplâncton nos intestinos de tilápia do Nilo cultivadas em três viveiros de peixes no sul do Egito, durante o período de outubro de 2012 a setembro. 2013. Indivíduos de tilápias foram colocados em aquários contendo água filtrada para detectar espécies de fitoplâncton não digeridas nas fezes. Resultados A maioria do fitoplâncton encontrado no intestino de tilápia do Nilo foi cianobactérias (36-50%) e clorofíceas (27-38%). Outros grupos, como Diatomáceas, Euglenophyta e Dinophyta, também foram encontrados em menores quantidades (<19%). As espécies fitoplanctônicas mais importantes e dominantes encontradas no intestino de tilápia foram as cianobactérias potencialmente tóxicas, Anabaena, Anabaenopsis, Cylindrospermopsis, Microcystis e Planktothrix. Apenas as diatomáceas foram registradas nas fezes, indicando a capacidade da tilápia de digerir todo o fitoplâncton, exceto espécies deste grupo. Conclusão Os dados deste estudo podem ser úteis para a biomanipulação de proliferação de fitoplâncton em ambientes aquicolas eutróficos.

Abstract Aim This study was carried out to determine which phytoplankton species, as a natural food, can be ingested and digested by Nile tilapia (Oreochromis niloticus L.). Methods During this study, phytoplankton in the gut contents of Nile tilapia collected from three fishponds in southern Egypt were investigated during the period Oct. 2012-Sep. 2013. Samples of tilapia fish were grown in aquarium containing filtered pond water to detect undigested phytoplankton species in the feces. Results The majority of the phytoplankton found in the gut of Nile tilapia was Cyanobacteria (36-50%) and Chlorophyta (27-38%). Other groups such Diatoms, Euglenophyta and Dinophyta were also found but with lower percentages (<19%). The most important and dominant phytoplankton species found in Tilapia gut were the potentially toxic cyanobacteria, Anabaena, Anabaenopsis, Cylindrospermopsis, Microcystis and Planktothrix. Only diatoms were recorded in the feces, indicating the ability of Tilapia to digest all phytoplankton except diatoms. Conclusions The data of this study could be useful for biomanipulation of nuisance phytoplankton blooms in eutrophic aquacultures.

A total of 244 lactic acid bacteria (LAB) strains were isolated from 180 dairy and pharmaceutical products that were collected from different areas in Minia governorate, Egypt. LAB were identified phenotypically on basis of morphological, physiological and biochemical characteristics. Lactobacillus isolates were further confirmed using PCR-based assay. By combination of phenotypic with molecular identification Lactobacillus spp. were found to be the dominant genus (138, 76.7%) followed by Streptococcus spp. (65, 36.1%) and Lactococcus spp. (27, 15%). Some contaminant organisms such as (Staphylococcus spp., Escherichia coli, Salmonella spp., mould and yeast) were isolated from the collected dairy samples but pharmaceutical products were free of such contaminants. Susceptibility of LAB isolates to antibiotics representing all major classes was tested by agar dilution method. Generally, LAB were highly susceptible to Beta-lactams except penicillin. Lactobacilli were resistant to vancomycin, however lactococci and streptococci proved to be very susceptible. Most strains were susceptible to tetracycline and showed a wide range of streptomycin MICs. The MICs of erythromycin and clindamycin for most of the LAB were within the normal range of susceptibility. Sixteen Lactobacillus,8 Lactococcus and 8 Streptococcus isolates including all tetracycline and/or erythromycin resistant strains were tested for the presence of tetracycline and/or erythromycin resistant genes [tet(M) and/or erm(B)]. PCR assays shows that some resistant strains harbor tet(M) and/or erm(B) resistance genes.

OBJECTIVES: To study the potential factors include gene mutation, efflux pump and alteration of permeability associated with quinolone-resistance of Salmonella enterica strains isolated from patients with acute gastroenteritis and to evaluate the degree of synergistic activity of efflux pump inhibitors when combined with ciprofloxacin against resistant isolates. METHODS: Antimicrobial resistance patterns of fifty-eight Salmonella isolates were tested. Five isolates were selected to study the mechanism of resistance associated with quinolone group, including mutation in topoisomerase-encoding gene, altered cell permeability, and expression of an active efflux system. In addition, the combination between antibiotics and efflux pump inhibitors to overcome the microbial resistance was evaluated. RESULTS: Five Salmonella isolates totally resistant to all quinolones were studied. All isolates showed alterations in outer membrane proteins including disappearance of some or all of these proteins (Omp-A, Omp-C, Omp-D and Omp-F). Minimum inhibitory concentration values of ciprofloxacin were determined in the presence/absence of the efflux pump inhibitors: carbonyl cyanide m-chlorophenylhydrazone, norepinephrin and trimethoprim. Minimum inhibitory concentration values for two of the isolates were 2-4 fold lower with the addition of efflux pump inhibitors. All five Salmonella isolates were amplified for gyrA and parC genes and only two isolates were sequenced. S. Enteritidis 22 had double mutations at codon 83 and 87 in addition to three mutations at parC at codons 67, 76 and 80 whereas S. Typhimurium 57 had three mutations at codons 83, 87 and 119, but no mutations at parC. CONCLUSIONS: Efflux pump inhibitors may inhibit the major AcrAB-TolC in Salmonella efflux systems which are the major efflux pumps responsible for multidrug resistance in Gramnegative clinical isolates.